Table 2

 Prevalence of COPD (FEV1/FVC <0.7) defined before and after bronchodilatation in a general adult population in 1996–7 by sex, age, body mass index, smoking habits, pack years, occupational exposure, and residential area

NPre-bronchodilator prevalent casesPost-bronchodilator prevalent casesPercentage reduction in prevalence after bronchodilatation relative to beforeEstimated post-bronchodilator prevalence (95% CI)
Sex
    Women1129654235%3.7% (2.6 to 4.8)
    Men110614911423%10.3% (8.5 to 12.1)
Age (years)
    26–44930442250%2.4% (1.4 to 3.3)
    45–59700412929%4.1% (2.7 to 5.6)
    60–74465887119%15.3% (12.0 to 18.6)
    75–82140413417%24.3% (17.1 to 31.5)
Body mass index (kg/m2)
    <20112161319%11.6% (5.6 to 17.6)
    20–24.99691127533%7.7% (6.1 to 9.4)
    25–29.9868695225%6.0% (4.4 to 7.6)
    >3027917166%5.7% (3.0 to 8.5)
Smoking habits
    Never smokers864462252%2.5% (1.5 to 3.6)
    Ex-smokers61975707%11.3% (8.8 to 13.8)
    Current smokers752936431%8.5% (6.5 to 10.5)
Pack years
    1–9541392633%4.8% (3.0 to 6.6)
    10–19408433616%8.8% (6.1 to 11.6)
    20+374796518%17.4% (13.5 to 21.2)
Educational level
    Primary404705817%14.4% (10.9 to 17.8)
    Secondary13111138029%6.1% (4.8 to 7.4)
    University494271544%3.0% (1.5 to 4.6)
Occupational exposure to gas or dust
    No1136815532%4.8% (3.6 to 6.1)
    Yes10491269425%9.0% (7.2 to 10.7)
Residential area
    Rural706644530%6.4% (4.6 to 8.2)
    Urban152915011126%7.3% (6.0 to 8.6)
Total223521415627%7.0% (5.9 to 8.0)